AstraZeneca has initiated a voluntary recall of a single production batch of its widely prescribed blood pressure medication Losartan Potassium 50mg tablets after a labeling error was discovered that listed an incorrect dosage strength on the bottle label. The affected batch, lot number AZ-2026-0318, was distributed to pharmacies in 12 states.
The labeling error indicated a dosage of 25mg rather than the actual 50mg strength of the tablets, creating a risk that patients or pharmacists could inadvertently double the intended dose. AstraZeneca reported that approximately 85,000 bottles from the batch were distributed before the error was identified during a routine quality audit.
Pharmacies have been notified to quarantine affected stock, and patients who received medications from the recalled batch should contact their pharmacist to verify their prescription. The company has implemented additional quality checkpoints to prevent similar labeling errors in the future.
